跳至主要内容
临床试验/IRCT20191205045621N2
IRCT20191205045621N2招募中未知

Evaluation of oral Medroxyprogesterone acetate effect in the prevention of premature LH surge in IVF cycles in comparison with antagonist protocol

Shiraz University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 42 years(—)
性别
Female

入选标准

  • age under 42 years
  • regular menstrual cycles over the previous 3-month period
  • antral follicle count (AFC) of 7-24 on menstrual cycle day 2–3
  • Normal TSH and Prolactin levels

排除标准

  • endometriosis grade 3 or higher
  • diagnosis of polycystic ovarian syndrome
  • presence of ovarian cyst
  • hormone treatment receipt within the previous 3-month period
  • low ovarian reserve (AMH<1.1 or AFC<7)
  • any contraindication to ovarian stimulation treatment
  • basal serum FSH concentration of more than 10 IU/L

研究者

相似试验